Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00127699 · ClinicalTrials.gov registry record · Phase 1
Triple Dye Plus Alcohol Versus Triple Dye Alone for Newborn Umbilical Cord Care
A Phase 1 study of Infection and Umbilical Cord, sponsored by Penn State University.
- Completed
- Registry status
- Phase 1
- Development phase
- 400
- Enrollment target
- 1
- Study location
NCT00127699: Completed Phase 1 study of Infection and Umbilical Cord, sponsored by Penn State University.
NCT00127699 is a Phase 1 study of Infection and Umbilical Cord that has completed, run by Penn State University. The registered enrollment target is 400 participants, below the 717-participant average among 41 other Infection trials with a reported enrollment target (44% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00127699, a Phase 1 study of Infection and Umbilical Cord, has completed, sponsored by Penn State University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 400 participants
- Enrollment target
- 1
- Study location
Study Summary
In the United States (U.S.) there currently is no standard method of umbilical cord care, resulting in varying practices within and across institutions. These differences may result in an increase in morbidities for newborns such as the formation of umbilical granulomas and increases in acute care utilization. This study will determine which of two common methods of caring for newborn umbilical cords is superior - triple dye, followed by the application of rubbing alcohol, or triple dye alone.
Conditions Studied
Interventions
- PROCEDURE Alcohol swab of umbilical cord
Study Locations (1)
Pennsylvania
- Penn State Milton S. Hershey Medical Center - Hershey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2005-08 |
| Est. Completion | 2007-08 |
| Phase | Phase 1 |
What the finished NCT00127699 record still lists
NCT00127699 is an interventional study that assigns participants to a tested intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, below the 717-participant average among 41 other Infection trials with a reported enrollment target (44% lower).
The record links to 2 conditions, with Infection appearing as the primary indexed condition, and to 1 intervention - of which Alcohol swab of umbilical cord is the first listed.
NCT00127699 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00127699 about?
NCT00127699 is a clinical study titled "Triple Dye Plus Alcohol Versus Triple Dye Alone for Newborn Umbilical Cord Care". In the United States (U.S.) there currently is no standard method of umbilical cord care, resulting in varying practices within and across institutions. These differences may result in an increase in morbidities for newborns such as the formation of umbilical granulomas and increases in acute care u...
What is the current status of trial NCT00127699?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 400 participants. The study started on 2005-08. Estimated completion is 2007-08.
What conditions does trial NCT00127699 study?
This clinical trial studies the following conditions: Infection, Umbilical Cord.
What interventions are being tested in trial NCT00127699?
The interventions under investigation include: Alcohol swab of umbilical cord (PROCEDURE).
Who is sponsoring clinical trial NCT00127699?
This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00127699 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00127699's enrollment target sits among peer trials
400 12th of 41 higher than 28 of 41 other Infection trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Infection trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
NADPH Oxidase Correction in mRNA-transfected Granulocyte-enriched Cells in Chronic Granulomatous Disease (CGD)
RECRUITING · Phase 1
-
Pharmacokinetics and Safety of Cefazolin 2g in DUPLEX
COMPLETED · Phase 1
-
Vancomycin Tissue Concentrations by Bier Block or Intravenous Administration
COMPLETED · Phase 1
-
Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation
COMPLETED · Phase 1
-
Chemotherapy and Peripheral Stem Cell Transplantation Followed By Immunotherapy in Treating Patients With Multiple Myeloma
COMPLETED · Phase 1
-
Home Hospital for Suddenly Ill Adults
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia